David Sinclair· PhD
The study showed the combo of senolytics (D+Q) preserved hearing in mice by targeting old, senescent cells in the cochlea, which secrete inflammatory molecules that affect normal tissue function
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
The study showed the combo of senolytics (D+Q) preserved hearing in mice by targeting old, senescent cells in the cochlea, which secrete inflammatory molecules that affect normal tissue function
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Senolytic molecules that clear aged cells (like dasatinib + quercetin), slow age-related hearing loss in mice by protecting cochlear cells & reducing inflammation.